De‐Escalation of Disease‐Modifying Therapy in Multiple Sclerosis—A Danish Nationwide Cohort Study
Frederik Elberling(Copenhagen University Hospital), Finn Sellebjerg(Danish Multiple Sclerosis Center), Melinda Magyari(University of Copenhagen), Mie Reith Mahler(Copenhagen University Hospital), Luigi Pontieri(Rigshospitalet)
Cited by 9
Related Papers
Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility
|Science|2019|1.4k
Worldwide Incidence and Prevalence of Neuromyelitis Optica
|Neurology|2020|303
Clinical Relevance of Brain Volume Measures in Multiple Sclerosis
|CNS Drugs|2014|293
Treatment Escalation vs Immediate Initiation of Highly Effective Treatment for Patients With Relapsing-Remitting Multiple Sclerosis
|JAMA Neurology|2021|237
Apparent changes in the epidemiology and severity of multiple sclerosis
|Nature Reviews Neurology|2021|209